B B Tysnes

Summary

Affiliation: University of Bergen
Country: Norway

Publications

  1. ncbi Bromelain reversibly inhibits invasive properties of glioma cells
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Bergen N 5009, Norway
    Neoplasia 3:469-79. 2001
  2. ncbi Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas
    B B Tysnes
    Department of Anatomy and Cell Biology, The Gade Institute, University of Bergen, Norway
    Invasion Metastasis 17:270-80. 1997
  3. ncbi Laminin expression by glial fibrillary acidic protein positive cells in human gliomas
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Int J Dev Neurosci 17:531-9. 1999
  4. ncbi Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro
    R Mahesparan
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Acta Neuropathol 97:231-9. 1999
  5. ncbi Biological mechanisms of glioma invasion and potential therapeutic targets
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    J Neurooncol 53:129-47. 2001
  6. ncbi Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors
    F Thorsen
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Cell Transplant 9:773-83. 2000
  7. ncbi The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
    M Chekenya
    Norlux Neuro Oncology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
    Oncogene 27:5182-94. 2008
  8. ncbi The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours
    M Chekenya
    Department of Anatomy and Cell Biology, University of Bergen, Bergen, Norway
    Neuropathol Appl Neurobiol 28:367-80. 2002
  9. ncbi Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2
    M Karlsen
    Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway
    Scand J Immunol 74:135-43. 2011

Detail Information

Publications9

  1. ncbi Bromelain reversibly inhibits invasive properties of glioma cells
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Bergen N 5009, Norway
    Neoplasia 3:469-79. 2001
    ..These results indicate that bromelain exerts its antiinvasive effects by proteolysis, signaling cascades, and translational attenuation...
  2. ncbi Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas
    B B Tysnes
    Department of Anatomy and Cell Biology, The Gade Institute, University of Bergen, Norway
    Invasion Metastasis 17:270-80. 1997
    ..These elements contribute to the characteristic features of glioma cells and may be an important part of the complex relationships between growth factors, integrins and extracellular matrix during glioma cell invasion...
  3. ncbi Laminin expression by glial fibrillary acidic protein positive cells in human gliomas
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Int J Dev Neurosci 17:531-9. 1999
    ..This glycoprotein may thus represent one important substrate among many, which contribute to the invasive phenotype of gliomas...
  4. ncbi Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro
    R Mahesparan
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Acta Neuropathol 97:231-9. 1999
    ..Furthermore, the presented findings support the notion that gliomas may utilize different cell surface receptors for their migration, depending on the cell substrates available...
  5. ncbi Biological mechanisms of glioma invasion and potential therapeutic targets
    B B Tysnes
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    J Neurooncol 53:129-47. 2001
    ..This will hopefully render promising new therapeutic targets for gliomas...
  6. ncbi Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors
    F Thorsen
    Department of Anatomy and Cell Biology, University of Bergen, Norway
    Cell Transplant 9:773-83. 2000
    ..Different producer cells may be encapsulated in alginate to target phenotypic features and microenvironmental factors, which may influence the progressive growth of brain tumors...
  7. ncbi The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
    M Chekenya
    Norlux Neuro Oncology Group, Department of Biomedicine, University of Bergen, Bergen, Norway
    Oncogene 27:5182-94. 2008
    ..Thus, as a novel regulator of the antiapoptotic response, NG2/MPG may represent an effective therapeutic target in several cancer subtypes...
  8. ncbi The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours
    M Chekenya
    Department of Anatomy and Cell Biology, University of Bergen, Bergen, Norway
    Neuropathol Appl Neurobiol 28:367-80. 2002
    ..Thus, the expression of NG2 may be indicative of tumour progression and might be an amenable target for future therapeutic interventions...
  9. ncbi Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2
    M Karlsen
    Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway
    Scand J Immunol 74:135-43. 2011
    ..In conclusion, bromelain treatment of monocyte-derived DC does not improve the functional quality compared with the standard cytokine cocktail...